An open label, randomizing, multicenter, phase III, comparator controlled parallel group study to assess the long term safety and efficacy of Lanthanum Carbonate in CRF patients recieving hemodialysis.

  • Mawad, Hanna (PI)
  • FRIEDLER, ROBERT (CoI)
  • Malluche, Hartmut (CoI)

Grants and Contracts Details

StatusFinished
Effective start/end date1/1/01 → 6/30/04